Stage IVB Lung Cancer AJCC v8 Recruiting Phase 2 Trials for Gemcitabine (DB00441)

DBCOND0111251 (Stage IVB Lung Cancer AJCC v8)Recruiting2 IdentifierTitlePurposeDrugs
NCT03971474Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)Treatment
NCT03662074Second Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung CancerTreatment